Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Ann Surg. 2022 Jan 1;275(1):e229–e237. doi: 10.1097/SLA.0000000000003945

Figure 3: Predictive potential of the 9-miRNA panel in an independent clinical validation cohort.

Figure 3:

(A) Kaplan-Meier analysis of the 9-miRNA signature for OS. (B) Forest plot depicting hazard ratios and 95% confidence intervals of the univariate significant clinicopathological variables as well as miRNA signature. Parameters colored in red are significant risk factors in multivariate analysis. (C) ROC for OS of the combined 9-miRNA signature and key clinicopathological parameters. (D) Nomogram derived from the combination of 9-miRNA signature and key clinicopathological parameters.